Literature DB >> 33968622

The significance of an integrated management mode of prenatal diagnosis-postnatal treatment for critical congenital heart disease in newborns.

Xiaohui Zhang1, Shaoru He2, Yumei Liu1, Jing Zhong1, Yunxia Sun1, Manli Zheng1, Juan Gui1, Ruixi Wang1, Bowen Feng1, Jianling Mo1, Minqiao Jian3, Caisheng Liu3, Yijing Liang1.   

Abstract

BACKGROUND: Congenital heart disease (CHD) is the most common congenital defect in human beings. The purpose of this article is to investigate impact of an integrated management mode of 'prenatal diagnosis-postnatal treatment' on birth, surgery, prognosis and complications associated with critical CHD (CCHD) in newborns.
METHODS: A retrospective analysis of the medical records of newborns diagnosed with CCHD were divided into two groups: prenatal diagnosis and postnatal diagnosis. The demographics, clinical characteristics, surgical status, prognosis and complications of the two groups were compared and the differences identified.
RESULTS: Among the 290 newborns with CCHD, 97 (33.4%) were prenatally diagnosed and 193 (66.6%) were postnatally diagnosed. Newborns in the prenatal diagnostic group were hospitalized immediately after birth, whereas the median age of admission was 6.00 (3.00-12.00) days in postnatal diagnostic group, P=0.000. In terms of postnatal symptoms and signs, the incidence of anhelation, cyanosis and cardiac murmur was higher in the postnatal diagnostic group. The rates of preoperative intubation, postoperative open chest exploration and treatment abandonment were higher in the postnatal diagnostic group. The postnatal diagnostic group was more prone to postoperative complications, such as pneumonia and hypoxic-ischemic brain damage. The preoperative mortality [0 (0.0%) vs. 12 (6.2%), P=0.028] in the prenatal diagnostic group was lower than that in the postnatal diagnostic group. And the one-year survival rate of the prenatal diagnostic group was higher (log-rank test P=0.034).
CONCLUSIONS: The integrated management mode of prenatal diagnosis-postnatal treatment can improve postnatal symptoms, reduces complications, reduces preoperative mortality and increases one-year survival rates in newborns with CCHD. 2021 Cardiovascular Diagnosis and Therapy. All rights reserved.

Entities:  

Keywords:  Fetus; critical congenital heart disease (critical CHD); integrated management; postnatal treatment; prenatal diagnosis

Year:  2021        PMID: 33968622      PMCID: PMC8102254          DOI: 10.21037/cdt-20-892

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  39 in total

1.  Detection of transposition of the great arteries in fetuses reduces neonatal morbidity and mortality.

Authors:  D Bonnet; A Coltri; G Butera; L Fermont; J Le Bidois; J Kachaner; D Sidi
Journal:  Circulation       Date:  1999-02-23       Impact factor: 29.690

Review 2.  The influence of prenatal diagnosis on postnatal outcome in patients with structural congenital heart disease.

Authors:  Robert S Yates
Journal:  Prenat Diagn       Date:  2004-12-30       Impact factor: 3.050

3.  Strategies for implementing screening for critical congenital heart disease.

Authors:  Alex R Kemper; William T Mahle; Gerard R Martin; W Carl Cooley; Praveen Kumar; W Robert Morrow; Kellie Kelm; Gail D Pearson; Jill Glidewell; Scott D Grosse; R Rodney Howell
Journal:  Pediatrics       Date:  2011-10-10       Impact factor: 7.124

4.  Relation of prenatal diagnosis with one-year survival rate for infants with congenital heart disease.

Authors:  Lydia K Wright; Alexandra Ehrlich; Nanci Stauffer; Cyrus Samai; Brian Kogon; Matthew E Oster
Journal:  Am J Cardiol       Date:  2013-12-25       Impact factor: 2.778

5.  Prenatal diagnosis of congenital heart disease and birth outcomes.

Authors:  Benjamin J Landis; Allison Levey; Stephanie M Levasseur; Julie S Glickstein; Charles S Kleinman; Lynn L Simpson; Ismee A Williams
Journal:  Pediatr Cardiol       Date:  2012-10-06       Impact factor: 1.655

6.  Impact of prenatal diagnosis on outcome of pulmonary atresia and intact ventricular septum.

Authors:  Giulia Tuo; Paolo Volpe; Sara Bondanza; Nicola Volpe; Margherita Serafino; Valentina De Robertis; Lucio Zannini; Giacomo Pongiglione; Maria Grazia Calevo; Maurizio Marasini
Journal:  J Matern Fetal Neonatal Med       Date:  2011-06-24

7.  Extra-corporeal life support, transradial thrombus aspiration and stenting, percutaneous blade and balloon atrioseptostomy, all as a bridge to heart transplantation to save one life.

Authors:  Ziad Dahdouh; Vincent Roule; Rémi Sabatier; Thérèse Lognoné; Fabien Labombarda; Arnaud Pellissier; Annette Belin; Calin Ivascau; Dimitrios Buklas; Massimo Massetti; Gilles Grollier
Journal:  Cardiovasc Revasc Med       Date:  2012-04-03

8.  The impact of prenatal diagnosis of complex congenital heart disease on neonatal outcomes.

Authors:  Allison Levey; Julie S Glickstein; Charles S Kleinman; Stephanie M Levasseur; Jonathan Chen; Welton M Gersony; Ismee A Williams
Journal:  Pediatr Cardiol       Date:  2010-02-18       Impact factor: 1.655

9.  Prenatal detection of congenital heart disease.

Authors:  Mark K Friedberg; Norman H Silverman; Anita J Moon-Grady; Elizabeth Tong; Jennifer Nourse; Beatrice Sorenson; Jaimie Lee; Lisa K Hornberger
Journal:  J Pediatr       Date:  2009-04-24       Impact factor: 4.406

Review 10.  Pulse oximetry screening for critical congenital heart defects.

Authors:  Maria N Plana; Javier Zamora; Gautham Suresh; Luis Fernandez-Pineda; Shakila Thangaratinam; Andrew K Ewer
Journal:  Cochrane Database Syst Rev       Date:  2018-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.